By Renova Hospitals
June 12, 2026
Cancer Immunotherapy Month June 2026: Meaning, Benefits, Side Effects, and Treatment Options
6 Key Takeaways from the Blog
- Cancer Immunotherapy Month is observed in June to raise awareness of cancer treatments that harness the body’s immune system to fight cancer cells.
- Cancer immunotherapy is a personalised treatment option and may be used only after proper diagnosis, staging, biopsy review, and biomarker testing.
- Immunotherapy is not suitable for every cancer patient. Eligibility depends on cancer type, stage, PD-L1/MSI/dMMR/TMB results, previous treatments, and overall health.
- Common cancers where immunotherapy may be considered include lung cancer, melanoma, kidney cancer, bladder cancer, head and neck cancer, liver cancer, lymphoma, leukaemia, and multiple myeloma.
- Immunotherapy can cause side effects such as fatigue, skin rash, diarrhoea, cough, thyroid changes, liver inflammation, or lung inflammation, so regular monitoring is important.
- Expert oncology consultation is essential because immunotherapy should be planned by cancer specialists through a multidisciplinary and patient-focused approach.
What Is Cancer Immunotherapy Month?
Cancer Immunotherapy Month is observed every June to raise awareness about cancer treatments that use the body’s immune system to fight cancer. It helps patients, caregivers, and families understand how immunotherapy works, which cancers may benefit from it, and why expert oncology consultation is important.
In June 2026, Cancer Immunotherapy Month is an important reminder that cancer treatment is becoming more personalised. Along with surgery, chemotherapy, radiation therapy, and targeted therapy, immunotherapy has become an important option for selected cancer patients.
What Is Cancer Immunotherapy?
Cancer immunotherapy is a treatment that helps the immune system recognise, target, and fight cancer cells. The immune system normally protects the body from infections and abnormal cells, but cancer cells can sometimes hide from immune attack.
Immunotherapy works by improving the body’s natural defence system. It may help immune cells identify cancer cells more clearly or remove signals that stop the immune system from attacking cancer.
Unlike chemotherapy, which directly kills fast-growing cells, immunotherapy supports the immune response. This is why immunotherapy may work differently and may also have different side effects compared to chemotherapy.
Why Is Cancer Immunotherapy Month Important in 2026?
Cancer Immunotherapy Month 2026 is important because many patients still do not know that cancer treatment can be personalised based on cancer type, stage, and biomarker testing.
Cancer care is no longer a one-size-fits-all approach. Two patients with the same cancer may receive different treatments depending on their biopsy report, stage, genetic markers, PD-L1 status, MSI/dMMR status, and overall health condition.
This awareness month helps people understand that early diagnosis, proper testing, and timely oncology consultation can improve treatment planning.
How Does Immunotherapy Work Against Cancer?
Immunotherapy works by helping immune cells detect and attack cancer cells more effectively. Some cancer cells escape the immune system by sending signals that switch off immune cells. Immunotherapy can block these signals and allow the immune system to respond better.
One common type of immunotherapy is called an immune checkpoint inhibitor. These medicines block proteins such as PD-1, PD-L1, or CTLA-4, which some cancers use to avoid immune attack.
By blocking these cancer-protecting signals, immunotherapy can help T cells identify and destroy cancer cells.
What Are the Main Types of Cancer Immunotherapy?
The main types of cancer immunotherapy include immune checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, cancer vaccines, and immune system modulators. Each type works differently and is used only when suitable for the patient’s cancer condition.
1. What Are Immune Checkpoint Inhibitors?
Immune checkpoint inhibitors are medicines that help immune cells attack cancer by blocking certain proteins that stop immune activity. They are used in selected cases of lung cancer, melanoma, kidney cancer, bladder cancer, liver cancer, and other cancers.
2. What Is CAR T-Cell Therapy?
CAR T-cell therapy is an advanced treatment where a patient’s immune cells are collected, modified in a laboratory, and given back to fight cancer. It is mainly used for certain blood cancers such as leukaemia, lymphoma, and multiple myeloma.
3. What Are Monoclonal Antibodies?
Monoclonal antibodies are laboratory-made proteins that attach to specific targets on cancer cells. They may help the immune system recognise cancer cells or deliver treatment directly to cancer cells.
4. What Are Cancer Vaccines?
Cancer vaccines help the immune system respond to cancer-related targets. Some vaccines can also help prevent virus-related cancers, such as the HPV vaccine, which reduces the risk of cervical cancer and other HPV-related cancers.
5. What Are Immune System Modulators?
Immune system modulators are treatments that boost or guide immune activity. They may be used in selected cancers based on specialist advice.
Which Cancers Can Be Treated with Immunotherapy?
Immunotherapy may be used in selected cases of lung cancer, melanoma, kidney cancer, bladder cancer, head and neck cancer, liver cancer, cervical cancer, lymphoma, leukaemia, and multiple myeloma.
However, immunotherapy is not suitable for every cancer patient. The decision depends on the cancer type, stage, biopsy findings, biomarker results, previous treatments, and the patient’s general health.
Common cancers where immunotherapy may be considered include:
- Lung cancer
- Melanoma
- Kidney cancer
- Bladder cancer
- Head and neck cancers
- Liver cancer
- Cervical cancer
- Certain colorectal cancers
- Hodgkin lymphoma
- Leukemia
- Lymphoma
- Multiple myeloma
Patients should consult a medical oncologist to know whether immunotherapy is suitable for their diagnosis.
Who Is Eligible for Cancer Immunotherapy?
A cancer patient may be eligible for immunotherapy if their cancer type, stage, biomarker test results, and overall health support its use. Oncologists decide eligibility after reviewing reports in detail.
Eligibility may depend on:
- Cancer type
- Stage of cancer
- Biopsy report
- PD-L1 test result
- MSI or dMMR status
- TMB or molecular testing
- Previous cancer treatments
- Current symptoms
- Liver, kidney, thyroid, and lung function
- Overall fitness for treatment
Not every patient needs immunotherapy. In some cases, chemotherapy, radiation therapy, targeted therapy, surgery, or a combination of treatments may be more appropriate.
What Tests Are Needed Before Starting Immunotherapy?
Before starting immunotherapy, doctors may recommend biopsy review, imaging scans, blood tests, PD-L1 testing, MSI/dMMR testing, TMB testing, or other molecular tests. These tests help predict whether immunotherapy may work for a patient.
Important tests may include:
- Biopsy and histopathology
- Immunohistochemistry
- CT scan, PET-CT, or MRI
- Blood tests
- Liver and kidney function tests
- Thyroid function tests
- PD-L1 testing
- MSI/dMMR testing
- Tumor mutational burden testing
- Next-generation sequencing, if required
These tests support precision oncology, where cancer treatment is selected based on the patient’s cancer biology.
Is Immunotherapy Better Than Chemotherapy?
Immunotherapy is not always better than chemotherapy; the best treatment depends on the cancer type, stage, and test results. In some cancers, immunotherapy may work better. In others, chemotherapy may still be the most effective treatment.
Chemotherapy directly attacks rapidly dividing cells. Immunotherapy helps the immune system fight cancer. Sometimes both treatments are used together for better results.
A medical oncologist may recommend immunotherapy alone, chemotherapy alone, or a combination depending on the patient’s condition.
Can Immunotherapy Be Combined with Other Cancer Treatments?
Yes, immunotherapy can sometimes be combined with chemotherapy, radiation therapy, targeted therapy, or surgery depending on the cancer type and stage.
Combination treatment may be recommended when doctors believe it can improve the response. For example, in some lung cancers, immunotherapy and chemotherapy may be used together. In some cancers, immunotherapy may be given after surgery or radiation to reduce the risk of recurrence.
The treatment plan should always be personalised by an oncology team.
What Are the Benefits of Cancer Immunotherapy?
The main benefit of cancer immunotherapy is that it helps the immune system fight cancer cells more effectively. In selected patients, immunotherapy may yield strong, longer-lasting responses.
Possible benefits include:
- Helps immune cells recognise cancer cells
- May provide a durable response in some cancers
- Can be used in selected advanced cancers
- May work when other treatments are less effective
- Supports personalised cancer treatment
- Can be combined with other cancer therapies
- May improve quality of life in selected patients
However, immunotherapy does not work for everyone. Some patients respond well, while others may not benefit. This is why patient selection and regular monitoring are very important.
What Are the Common Side Effects of Immunotherapy?
Common immunotherapy side effects include fatigue, skin rash, itching, fever, diarrhoea, cough, breathing difficulty, joint pain, thyroid changes, liver inflammation, and lung inflammation.
Immunotherapy can sometimes make the immune system attack healthy organs. These are called immune-related side effects. They may affect the skin, lungs, liver, intestines, thyroid gland, kidneys, or other organs.
Patients should inform their oncology team immediately if they notice:
- New cough
- Breathlessness
- Severe diarrhea
- Yellowing of eyes
- Severe tiredness
- Skin rash
- Fever
- Chest pain
- Persistent headache
- Sudden weakness
- Reduced urine output
Early reporting can help doctors manage side effects safely.
Is Immunotherapy Painful?
Immunotherapy is usually not painful because many immunotherapy medicines are administered via IV infusion. Some patients may feel mild discomfort during IV cannula placement, but the treatment itself is generally not painful.
The main concern is not pain during infusion but possible side effects after treatment. Patients need regular follow-up, blood tests, and symptom monitoring during immunotherapy.
Can Immunotherapy Cure Cancer Completely?
Immunotherapy can give long-lasting responses in some cancer patients, but it is not a guaranteed cure for every cancer. The outcome depends on the cancer type, stage, biomarkers, treatment response, and overall health.
Some patients respond very well to immunotherapy. Others may have partial response, stable disease, or no response. Doctors monitor the response through scans, blood tests, symptoms, and clinical examination.
Why Is Biomarker Testing Important Before Immunotherapy?
Biomarker testing is important because it helps doctors understand whether a cancer may respond to immunotherapy. It gives information about the cancer’s behaviour and treatment sensitivity.
Common biomarkers used in immunotherapy decision-making include:
- PD-L1
- MSI-H
- dMMR
- TMB
- Specific genetic mutations
- Molecular profiling results
Biomarker testing helps oncologists avoid unnecessary treatment and select the most suitable therapy for each patient.
What Are the Myths About Cancer Immunotherapy?
Many myths about cancer immunotherapy can create confusion and delay treatment. Patients should discuss treatment doubts directly with their oncologist.
Myth 1: Immunotherapy works for all cancers
Fact: Immunotherapy works only in selected cancers and selected patients.
Myth 2: Immunotherapy has no side effects
Fact: Immunotherapy can cause immune-related side effects that need medical monitoring.
Myth 3: Immunotherapy always replaces chemotherapy
Fact: Chemotherapy, surgery, radiation, or targeted therapy may still be needed.
Myth 4: Immunotherapy gives immediate results
Fact: Some patients respond slowly, and doctors monitor progress through scans and clinical review.
Myth 5: Online reports can decide immunotherapy eligibility
Fact: Only an oncologist can decide suitability after reviewing all reports.
Cancer Immunotherapy in Hyderabad: Why Expert Consultation Matters
Patients looking for cancer immunotherapy in Hyderabad should consult an experienced medical oncologist for proper diagnosis, biomarker testing, and treatment planning. Immunotherapy should not be started without complete evaluation.
Cancer treatment requires a multidisciplinary approach involving medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists, and supportive care specialists. This team-based approach helps create a safer and more effective treatment plan.
How Can Patients Prepare for Immunotherapy?
Patients preparing for immunotherapy should share their full medical history, previous treatments, allergies, autoimmune conditions, current medicines, and recent test reports with their oncologist.
Before treatment, patients should:
- Carry all biopsy and scan reports
- Inform doctors about autoimmune diseases
- Share thyroid, liver, kidney, or lung problems
- Mention all ongoing medicines
- Report infections or fever
- Understand possible side effects
- Follow the treatment schedule
- Attend regular follow-up visits
Good communication with the oncology team improves safety during treatment.
Key Takeaway
Cancer immunotherapy is an advanced cancer treatment that helps the immune system fight cancer cells, but it is suitable only for selected patients after proper testing. Cancer Immunotherapy Month in June 2026 is the right time to raise awareness about early diagnosis, biomarker testing, personalised treatment, and expert oncology care.
Patients should not delay cancer consultation or depend only on online information. The right treatment decision should always be made after specialist evaluation.
Consult Cancer Specialists at Renova Hospitals
At Renova Hospitals, cancer care is planned through a multidisciplinary and patient-focused approach. Our oncology team evaluates each patient carefully and guides them through diagnosis, staging, biomarker testing, chemotherapy, immunotherapy, targeted therapy, radiation therapy, surgery, and follow-up care.
If you or your loved one has been diagnosed with cancer, consult the cancer specialists at Renova Hospitals to understand whether immunotherapy or other advanced cancer treatments are suitable.
Book an appointment with Renova Hospitals today for expert cancer consultation and personalised treatment guidance.
Category
- Joint Replacement
- Joint Replacement
- Joint Replacement
- Joint Replacement
- Joint Replacement
- Joint Replacement
